Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Ureteral Drainage After Flexible URS for Kidney Stones: External Catheter vs Internal Stent

Official title: One-Day External Ureteral Catheter Versus Double-J Internal Ureteral Stent After Retrograde Intrarenal Surgery for Renal Stones: A Prospective, Randomized Trial

Run by Al-Azhar University · NCT05738304 · Data updated 2026-11-12

This study tests whether a one-day external ureteral catheter works as well as a standard internal stent after a flexible ureteroscopy for kidney stones in adults.

More Kidney Stone trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment250 (estimated)
SponsorAl-Azhar University
Academic / other
Locations1 site (Cairo)
StatusRecruiting
StartedJanuary 12, 2021
Main results expectedNovember 1, 2026
Study endsJanuary 1, 2027
Registry record updatedAugust 24, 2026
Trial IDNCT05738304 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults undergoing retrograde flexible URS for renal stones who do not have active infection, solitary kidney, pregnancy, or other interventions required in the same setting.

Probably not a fit

Patients with complicated intraoperative events requiring a specific stenting approach or those not fitting the study criteria may not benefit from this comparison.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Researchers will compare two ureteral drainage methods after retrograde flexible intrarenal surgery for renal stones: a short external ureteral catheter placed temporarily versus a double-J internal ureteral stent. The goal is to see which method provides similar stone clearance but with fewer stent-related symptoms and complications. The trial will look at outcomes such as stone-free rate, postoperative complications, and patient experience related to stent symptoms. Eligible participants are adults undergoing RIRS for renal stones, with certain exclusions such as pregnancy or active infection. The study is sponsored by Al-Azhar University and conducted at its Cairo hospital.

Why it matters

Potential benefit: If external catheters prove as effective as internal stents, patients may experience fewer stent-related symptoms and a simpler postoperative course.

How similar studies have gone: Prior studies comparing external catheters to internal stents after URS have yielded mixed results and often combined different stone scenarios, making direct conclusions inconclusive.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

• Adult patients of either gender in whom RIRS was the primary modality.

Exclusion Criteria:

* Pregnant women
* Active urinary tract infection
* solitary kidney
* Concomitant pathology that need intervention in the same setting
* Patients with surgical incidents that indicate double-J stenting (Residual sizable fragments, ureteral false passage, ureteral mucosal laceration, ureteral perforation, and calyceal rupture).

Where it's running

  • Urology Department, Al-Azhar University Hospital
    Cairo, Egypt
    Recruiting

Study contacts

  • Principal investigator: Abul-fotouh Ahmed — Department of Urology, Faculty of Medicine, Al-Azhar University, Cairo, Egypt
  • Study coordinator: Abul-fotouh Ahmed, MD
  • Email: abulfotouhahmed@yahoo.com
  • Phone: 00201001066756

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.